IT1224222B - Uso di bromocriptina nelle affezioni auto-immuni - Google Patents

Uso di bromocriptina nelle affezioni auto-immuni

Info

Publication number
IT1224222B
IT1224222B IT48160/87A IT4816087A IT1224222B IT 1224222 B IT1224222 B IT 1224222B IT 48160/87 A IT48160/87 A IT 48160/87A IT 4816087 A IT4816087 A IT 4816087A IT 1224222 B IT1224222 B IT 1224222B
Authority
IT
Italy
Prior art keywords
bromocriptina
affections
immune
auto
immune affections
Prior art date
Application number
IT48160/87A
Other languages
English (en)
Italian (it)
Other versions
IT8748160A0 (it
Inventor
Douglas Larson
Peter Hiestand
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8748160A0 publication Critical patent/IT8748160A0/it
Application granted granted Critical
Publication of IT1224222B publication Critical patent/IT1224222B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT48160/87A 1986-07-14 1987-07-10 Uso di bromocriptina nelle affezioni auto-immuni IT1224222B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88511086A 1986-07-14 1986-07-14

Publications (2)

Publication Number Publication Date
IT8748160A0 IT8748160A0 (it) 1987-07-10
IT1224222B true IT1224222B (it) 1990-09-26

Family

ID=25386156

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48160/87A IT1224222B (it) 1986-07-14 1987-07-10 Uso di bromocriptina nelle affezioni auto-immuni

Country Status (13)

Country Link
JP (1) JPS6323817A (cs)
KR (1) KR880001292A (cs)
AU (1) AU602154B2 (cs)
CH (1) CH672987A5 (cs)
DE (1) DE3722383A1 (cs)
DK (1) DK363887A (cs)
FR (1) FR2601245A1 (cs)
GB (1) GB2192541B (cs)
IT (1) IT1224222B (cs)
NL (1) NL8701631A (cs)
PH (1) PH24525A (cs)
SE (1) SE8702843L (cs)
ZA (1) ZA875145B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814521A1 (de) * 1987-05-07 1988-11-17 Sandoz Ag Neue anwendung von dopaminrezeptor-agonisten
EP0327040A3 (de) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Verwendung von Dopamin und/oder von Dopamin-Agonisten zur Herstellung eines Arzneimittels für die Behandlung des Verdauungstrakts
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US5830895A (en) * 1988-05-10 1998-11-03 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for the determination and adjustment of prolactin daily rhythms
US5716932A (en) * 1988-05-10 1998-02-10 Louisiana State University And Agricultural And Mechanical College Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
CZ282909B6 (cs) * 1991-12-23 1997-11-12 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Použití agonisty dopaminu a stimulátoru prolaktinu pro přípravu farmaceutického přípravku a tento farmaceutický přípravek
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5714519A (en) * 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US5626860A (en) * 1995-06-07 1997-05-06 The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
US20090325997A1 (en) * 2006-11-23 2009-12-31 Ergonex Pharma Gmbh Pharmaceutical Compositions For The Treatment Of Capillary Arteriopathy
EP3925610A1 (en) * 2016-04-20 2021-12-22 VeroScience LLC Composition and method for treating metabolic disorders
WO2019079623A1 (en) 2017-10-18 2019-04-25 Veroscience Llc ENHANCED BROMOCRIPTINE FORMULATIONS
CA3149877A1 (en) 2019-09-23 2021-04-01 Anthony H. Cincotta Method for inducing tumor regression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.

Also Published As

Publication number Publication date
KR880001292A (ko) 1988-04-22
DE3722383A1 (de) 1988-01-28
DK363887D0 (da) 1987-07-13
SE8702843L (sv) 1988-01-15
GB2192541A (en) 1988-01-20
DK363887A (da) 1988-01-15
JPS6323817A (ja) 1988-02-01
SE8702843D0 (sv) 1987-07-13
AU7558787A (en) 1988-01-21
GB2192541B (en) 1990-05-02
FR2601245A1 (fr) 1988-01-15
AU602154B2 (en) 1990-10-04
IT8748160A0 (it) 1987-07-10
ZA875145B (en) 1989-02-22
NL8701631A (nl) 1988-02-01
CH672987A5 (cs) 1990-01-31
GB8716323D0 (en) 1987-08-19
PH24525A (en) 1990-07-18

Similar Documents

Publication Publication Date Title
IT1224222B (it) Uso di bromocriptina nelle affezioni auto-immuni
DE3790726T1 (de) Kosmetikprobe
IT8667542A0 (it) Meddi d ausilio per l uso di servizi igienici
DK683987A (da) Topisk farmaceutisk praeparat til anvendelse i form af tape
DK237187A (da) Farmaceutisk anvendelse af t-pa
DK184087A (da) Farmaceutiske praeparater med forbedret biotilgaengelighed
DK633587A (da) Farmakologisk/kosmetisk praeparat
DK668487A (da) Kosmetisk praeparat
IT1214611B (it) Composti per uso cosmetico dermatologico e relative composizioni.
KR880701524A (ko) 1-옥소히드로카르빌-치환 아자시클로헥산으로 되는 조성물 및 그의 용도
DK400487D0 (da) Transdermale praeparater
NO882650L (no) Preparater for benyttelse i permanent endring av haarfarge.
IT1224171B (it) Miglioramenti nelle criopompe
DK465487A (da) Anxiolytiske praeparater indeholdende dioxopiperidinderivater
IT8722217A0 (it) Metodo d'uso selettivo di ossabicicloalcani:
FR2593392B1 (fr) Composition cosmetique
SE8705060D0 (sv) Antiforkylningssats, antiforkylningspreparat och anvendning derav
IT1217177B (it) Palmitoil-fruttosio-1,6-difosfato,suo uso terapeutico e relativi metodi di preparazione
IT1232167B (it) Uso cosmetico di acido 3-indolpiruvico
IT1231426B (it) Preparazione di polifluoroenolati
FI870557L (fi) Dermala och transdermala plaoster.
IT1214610B (it) Composto per uso cosmetico dermatologico e relative composizioni.
NO168871C (no) Anvendelse av transportoer i sedimenteringsbasseng
ES1000381Y (es) Calzado biolectromagnetico para uso terapeutico y general
FI873179A7 (fi) Uudet tetrahydrobentsotiatsolo-kinoliinitniiden valmistus ja käyttö.